Crinetics Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Crinetics Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $85.5. The average 1-year stock price forecast is 0.88% higher than the current stock price, while the lowest is $85 (+0.29%) and the highest is $90 (+6.19%).

Price Target: $85.5 (+0.88%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$85	$85.5	$85	$90
Change	+0.29%	+0.88%	+0.29%	+6.19%

Analyst Ratings

The average analyst rating for Crinetics Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	12	12	12	12	1	1
Buy	3	3	3	3	0	0
Hold	1	1	1	1	13	13
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	16	16	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Douglas Tsao H.C. Wainwright	H.C. Wainwright	Hold Reiterates $85	Hold	Reiterates	$85	+0.29%	Aug 11, 2026
Ashwani Verma UBS	UBS	Hold Downgrades $55 → $85	Hold	Downgrades	$55 → $85	+0.29%	Jul 28, 2026
Kate Dellorusso LifeSci Capital	LifeSci Capital	Hold Maintains $85	Hold	Maintains	$85	+0.29%	Jul 11, 2026
Alex Thompson CFA Stifel Nicolaus	Stifel Nicolaus	Hold Downgrades $83 → $85	Hold	Downgrades	$83 → $85	+0.29%	Jul 8, 2026
Gavin Clark-Gartner Evercore ISI	Evercore ISI	Hold Downgrades $88 → $85	Hold	Downgrades	$88 → $85	+0.29%	Jul 8, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

58.81M

from 7.70M

664.20%

from 7.70M

Revenue Next Year

180.65M

from 58.81M

207.16%

from 58.81M

EPS This Year

-4.13

from -4.95

EPS Next Year

-4.00

from -4.13

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.08M	4.74M	4.01M	1.04M	7.70M	58.81M
Revenue Growth	1,418.31%	339.43%	-15.28%	-74.11%	640.71%	664.20%
Operating Income	-107.70M	-167.88M	-222.61M	-338.85M	-516.77M	-478.08M
Net Income	-107.64M	-163.92M	-214.53M	-298.41M	-465.32M	-507.45M
EPS	-	-	-	-	-4.95	-4.13
Free Cash Flow	-48.47M	-62.51M	-93.53M	-136.41M	-206.91M	-417.67M
No. Analysts	-	-	-	-	-	1

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	58.8M
Avg	58.8M
Low	58.8M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	664.2%
Avg	664.2%
Low	664.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-4.00
Avg	-4.13
Low	-4.24

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-